D'Archangelo Melissa J
Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA.
J Diabetes Sci Technol. 2009 Mar 1;3(2):363-5. doi: 10.1177/193229680900300218.
Continuous glucose monitoring (CGM) is a new technology that allows patients to measure glucose levels continuously over several days. It has several advantages over traditional glucose meters in that it does not involve repeated finger sticks and can measure trends and track changes in glucose levels over time. The Clinical and Laboratory Standards Institute, working with the Diabetes Technology Society, published Performance Metrics for Continuous Interstitial Glucose Monitoring; Approved Guideline, which provides recommendations for methods for determining analytical and clinical metrics of CGMs. The document provides guidance on how CGM data should be presented, compared between devices, and compared between measurement technologies. The document serves as a roadmap for the testing of CGM devices and will ultimately advance the potential of this exciting technology. Performance Metrics for Continuous Interstitial Glucose Monitoring; Approved Guideline represents the consensus view on preparing and presenting CGM data.
连续血糖监测（CGM）是一项新技术，它能让患者在数天内持续测量血糖水平。与传统血糖仪相比，它有几个优点，即无需反复扎手指采血，并且能够测量血糖水平随时间的变化趋势并进行跟踪。临床和实验室标准协会与糖尿病技术协会合作，发布了《连续组织间液葡萄糖监测性能指标；批准指南》，该指南为确定CGM分析和临床指标的方法提供了建议。该文件就CGM数据应如何呈现、不同设备之间的数据比较以及不同测量技术之间的数据比较提供了指导。该文件是CGM设备测试的路线图，并将最终提升这项令人兴奋的技术的潜力。《连续组织间液葡萄糖监测性能指标；批准指南》代表了关于CGM数据准备和呈现的共识观点。
